P. Harker-Murray

发表

Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis.

J. Talano, Craig Erker, P. Harker-Murray, 2017, Pediatric clinics of North America.

expressed on artificial antigen-presenting cells of tumor necrosis factor receptor family members OX40 and 4-1BB Umbilical cord blood regulatory T-cell expansion and functional effects

J. Wagner, C. June, Jeffrey S. Miller, 2013 .

Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.

J. Wagner, C. June, Jeffrey S. Miller, 2008, Blood.

Emerging immunotherapy in pediatric lymphoma.

M. Burke, Craig Erker, P. Harker-Murray, 2016, Future oncology.

A New Model for Stratification of Treatment Intensity in Relapsed Pediatric Hodgkin Lymphoma

K. Kelly, D. Hodgson, P. Cole, 2014, Klinische Pädiatrie.

A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma

S. Perkins, I. Kirov, B. Shiramizu, 2021, Leukemia.

Novel Therapies Potentially Available for Pediatric B-Cell Non-Hodgkin Lymphoma.

M. Barth, P. Harker-Murray, L. Pommert, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Open-label Bendamustine Monotherapy for Pediatric Patients With Relapsed or Refractory Acute Leukemia: Efficacy and Tolerability

L. Frankel, I. Kirov, P. Brown, 2014, Journal of pediatric hematology/oncology.

Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post‐transplant lymphoproliferative disorder after kidney transplantation

M. Ardura, A. Weinberg, K. Twombley, 2012, Pediatric transplantation.

Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia.

S. Kehl, T. Walsh, A. Huppler, 2017, Journal of pediatric hematology/oncology.

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma

Steve Y. Cho, M. Loh, Zhiguo Chen, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin.

N. Key, M. Steiner, J. Foker, 2007, The Annals of thoracic surgery.

Posterior Reversible Encephalopathy Syndrome in the Setting of Asparaginase-associated Pancreatitis in 2 Pediatric Patients With Acute Leukemia

P. Harker-Murray, Amanda Scheuermann, L. Pommert, 2021, Journal of pediatric hematology/oncology.

Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation

K. Bone, John M. Astle, Amanda M. Hopp, 2022, Journal of pediatric hematology/oncology.

Long‐term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group

C. Pierson, T. Horton, G. Dhall, 2018, Pediatric blood & cancer.

Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231

Steve Y. Cho, M. Loh, Zhiguo Chen, 2020 .

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Avis J. Thomas, J. Wagner, J. Tolar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations

J. Kahn, J. Shoag, P. Harker-Murray, 2023, Advances in Oncology.

Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation

J. Tolar, M. Schleiss, P. Ferrieri, 2008, Pediatric blood & cancer.

A complex KMT2A::AFF3 fusion resulting from a three-way chromosomal rearrangement in pediatric B lymphoblastic leukemia.

K. Bone, Holli M. Drendel, P. Harker-Murray, 2021, Cancer genetics.

Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma

Shaun Parsons, S. Castellino, B. Hoppe, 2023, Pediatric blood & cancer.

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

R. Norris, A. Mauguen, A. Yan, 2023, Blood advances.

Response-Adapted Therapy with Nivolumab and Brentuximab Vedotin (BV), Followed By BV and Bendamustine for Suboptimal Response, in Children, Adolescents, and Young Adults with Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma

K. Kelly, T. Leblanc, L. Brugières, 2018, Blood.

Nivolumab and brentuximab vedotin (BV)-based, response‐adapted treatment in children, adolescents, and young adults (CAYA) with standard-risk relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Primary analysis.

K. Kelly, T. Leblanc, M. Puhlmann, 2020 .

Adherence of published diabetes mellitus practice guidelines to methodologic standards of guideline development.

V. Montori, Steven A. Smith, P. Harker-Murray, 2002, Endocrinology and metabolism clinics of North America.